Skip to main content

Sartorius

Sartorius AG is a German laboratory and pharmaceutical equipment enterprise that provides cutting-edge technologies and products for life science research and biopharmaceutical manufacturing. The company operates through two primary business segments covering Bioprocess Solutions and Lab Products and Services. Its principal products encompass single-use bioprocessing equipment, filtration systems, fermentation bioreactors, laboratory balances, and liquid handling instruments. Revenue is driven primarily through the commercial sale of consumable filtration units and laboratory hardware to biotechnology companies, pharmaceutical firms, and academic research institutions. The primary end markets comprise biopharmaceutical production facilities, research laboratories, and clinical testing centers globally. As a prominent participant in life science instrumentation, the enterprise holds a leading position in bioprocess technology. Headquartered in Göttingen, Germany, Sartorius AG is publicly listed on the Frankfurt Stock Exchange under the ticker symbol SRT.

42 of the funds FundTelligence covers report a position in Sartorius.

Legal name
Sartorius AG
Sector
Health Care
Country
Germany
Funds holding it
42

Funds holding Sartorius

Showing the 8 largest of 42 funds holding it.

Loading...